The Food and Drug Administration on Friday unveiled a long-term strategy to prevent future infant formula shortages.

Abbott and Reckitt's Mead Johnson face over 1,000 claims that preterm infant formula causes necrotizing enterocolitis (NEC) in infants and have been hit with jury verdicts totaling a half a ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

Finance reported: Abbott Laboratories has been ordered to pay almost $500MM over allegations that it hid the risk that its infant formula for premature babies can cause serious illness.

The latest trading session saw Abbott (ABT) ending at $114.31 ... Shares of the maker of infant formula, medical devices and drugs have depreciated by 3% over the course of the past month ...

In the latest market close, Abbott (ABT) reached $113.29 ... Prior to today's trading, shares of the maker of infant formula, medical devices and drugs had lost 4.04% over the past month.